Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
NCT03069170
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
Stem Cell Transplantation
Sponsor
Stem Cells Arabia